You have 9 free searches left this month | for more free features.

imatinib

Showing 1 - 25 of 124

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Inherited Bone Marrow Failure Syndrome, Familial Platelet Disorder With Predisposition to Myeloid Malignancies Trial run by the

Not yet recruiting
  • Inherited Bone Marrow Failure Syndrome
  • Familial Platelet Disorder With Predisposition to Myeloid Malignancies
  • imatinib
  • TruSight Oncology
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 20, 2023

Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • San Francisco, California
    University of California, San Francisco
Dec 6, 2022

GIST Trial in Xi'an (Imatinib)

Recruiting
  • GIST
  • Imatinib
  • Xi'an, Shaanxi, China
    Xijing Hospital of Air Force Military Medical University
Jun 8, 2023

Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck Trial in Madison (Cetuximab, Imatinib)

Recruiting
  • Head and Neck Cancer
  • Squamous Cell Carcinoma of Head and Neck
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Apr 24, 2023

Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

Not yet recruiting
  • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
  • (no location specified)
Jun 7, 2022

Gastrointestinal Stromal Tumors Trial in Lexington (Imatinib)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Imatinib
  • Lexington, Kentucky
    Markey Cancer Center
Aug 5, 2022

Sarcoma Trial in Helsinki (Imatinib)

Recruiting
  • Sarcoma
  • Imatinib
  • Helsinki, Finland
    Helsinki University Central Hospital
Sep 26, 2022

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)

Recruiting
  • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
  • Imatinib
  • +3 more
  • Frankfurt, Germany
    Department of Medicine, Hematology and Oncology, Goethe Universi
Sep 24, 2023

Gastrointestinal Stromal Tumors Trial in Tokyo (Pimitespib, Imatinib, Sunitinib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Tokyo, Japan
    A site selected by Taiho Pharmaceutical Co., Ltd.
Aug 4, 2022

Advanced, Refractory Cancer Trial in Seoul (Imatinib)

Active, not recruiting
  • Advanced, Refractory Cancer
  • Imatinib
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Tuberculosis Trial in Atlanta (Imatinib, Isoniazid, Rifabutin)

Recruiting
  • Tuberculosis
  • Imatinib
  • +2 more
  • Atlanta, Georgia
    Emory University DAIDS TB Non-Network CRS
Jan 20, 2022

CML, Chronic Phase Trial in Harbin (Flumatinib, Imatinib)

Not yet recruiting
  • CML, Chronic Phase
  • Harbin, Heilongjiang, China
    Institute of Hematology and Oncology, Harbin The First Hospital
May 5, 2022

Ph+ ALL Trial in China (Olverembatinib, Imatinib)

Recruiting
  • Ph+ ALL
  • Chongqing, Chongqing, China
  • +8 more
Sep 22, 2023

ALK+ Anaplastic Large Cell Lymphoma Trial in Wien (Brentuximab vedotin, Imatinib)

Terminated
  • ALK+ Anaplastic Large Cell Lymphoma
  • Brentuximab vedotin
  • Imatinib
  • Wien, Austria
    Universitätsklinik f. Innere Medizin I, AKH Wien, Klinische Abte
Feb 15, 2022

Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • Detroit, Michigan
  • +1 more
May 3, 2022

Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases

Recruiting
  • Eosinophilic Myeloid Neoplasm
  • Hypereosinophilic Syndrome
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Chronic Myeloid Leukemia, Chronic Phase Trial in Beijing (Radotinib, Imatinib)

Active, not recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Beijing, China
    Peking University People's Hospital(北京大学人民医院)
Jan 3, 2022

CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)

Recruiting
  • CML
  • +3 more
  • Asciminib add-on
  • +3 more
  • Augusta, Georgia
  • +46 more
Jan 23, 2023

Acute Leukemia Trial in Tianjin (Flumatinib, Imatinib)

Recruiting
  • Acute Leukemia
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Sep 27, 2021

Covid19, Coronavirus Disease 2019, SARS-CoV-2 Acute Respiratory Disease Trial in Helsinki (Imatinib, Infliximab)

Recruiting
  • Covid19
  • +2 more
  • Helsinki, Finland
    University of Helsinki
Apr 27, 2022

Rare Malignant Tumor Trial (Imatinib)

Not yet recruiting
  • Rare Malignant Neoplasm
  • Imatinib
  • (no location specified)
Nov 1, 2023

Progression-free Survival, Gastrointestinal Stromal Tumor, Neoadjuvant Trial in Hangzhou (Imatinib)

Recruiting
  • Progression-free Survival
  • +2 more
  • Imatinib
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Oct 9, 2021

Gastrointestinal Stromal Tumors Trial in Seoul (imatinib)

Active, not recruiting
  • Gastrointestinal Stromal Tumors
  • imatinib
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Jun 22, 2021

Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated

Completed
  • Chronic Myeloid Leukaemia
  • Imatinib
  • Rionero in Vulture, Potenza, Italy
  • +32 more
Oct 24, 2022

Landscape and Real-life Treatment Outcomes in Hungary: Analysis

Completed
  • Chronic Myeloid Leukaemia
  • Budapest, Hungary
    Pfizer
Dec 15, 2022